Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes

BACKGROUND: SGLT2 inhibitors are a new class of drugs that act by inhibiting glucose reabsorption in the proximal renal tubules. Many trials have demonstrated their effectiveness in reducing glycated hemoglobin (HbA1c) and weight, but they have never been examined in Arab or Emirati populations. MET...

詳細記述

保存先:
書誌詳細
出版年:J Clin Med Res
主要な著者: Bashier, Alaaeldin, Khalifa, Azza Abdulaziz, Rashid, Fauzia, Abdelgadir, Elamin Ibrahim, Al Qaysi, Amina Adil, Ali, Razan, Eltinay, Ahmed, Nafach, Jalal, Alsayyah, Fatima, Alawadi, Fatheya
フォーマット: Artigo
言語:Inglês
出版事項: Elmer Press 2017
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412523/
https://ncbi.nlm.nih.gov/pubmed/28496550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2976w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料